Hyunji Jo

523 total citations
36 papers, 372 citations indexed

About

Hyunji Jo is a scholar working on Oncology, Molecular Biology and Toxicology. According to data from OpenAlex, Hyunji Jo has authored 36 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Molecular Biology and 7 papers in Toxicology. Recurrent topics in Hyunji Jo's work include Cancer therapeutics and mechanisms (8 papers), Bioactive Compounds and Antitumor Agents (7 papers) and Synthesis and biological activity (4 papers). Hyunji Jo is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Bioactive Compounds and Antitumor Agents (7 papers) and Synthesis and biological activity (4 papers). Hyunji Jo collaborates with scholars based in South Korea, United States and Japan. Hyunji Jo's co-authors include Youngjoo Kwon, Younghwa Na, Aarajana Shrestha, Hye Ryeon Kim, Soo‐Yeon Hwang, Hong-Sik Kim, KyeongJin Kang, Hyung‐Wook Kim, Eung-Seok Lee and Min Sung Choi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Chemical Communications.

In The Last Decade

Hyunji Jo

35 papers receiving 367 citations

Peers

Hyunji Jo

ONCOL

PRM

HEMAT

J. C. Mani France

John van Duzer United States

Mu‐Chun Li Taiwan

José Manuel Lerma-Díaz Mexico

Reza Tabaripour Iran

Hao Wei China

Roberta Rossi Italy

Maura McDonnell United States

Alessandra Pasquali Italy

Umesh Hanumegowda United States

J. C. Mani France

Hyunji Jo

198 ×1.7

62 ×0.7

ONCOL

69 ×0.9

15 ×0.3

PRM

25 ×0.5

HEMAT

Citations per year, relative to Hyunji Jo Hyunji Jo (= 1×) peers J. C. Mani

Countries citing papers authored by Hyunji Jo

Since Specialization

Citations

This map shows the geographic impact of Hyunji Jo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyunji Jo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyunji Jo more than expected).

Fields of papers citing papers by Hyunji Jo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyunji Jo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyunji Jo. The network helps show where Hyunji Jo may publish in the future.

Co-authorship network of co-authors of Hyunji Jo

This figure shows the co-authorship network connecting the top 25 collaborators of Hyunji Jo. A scholar is included among the top collaborators of Hyunji Jo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyunji Jo. Hyunji Jo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Jin‐Hong, et al.. (2025). Accuracy, generalizability, and extrapolation ability of physics-based, data-driven, and hybrid models for real-life cooling towers. Building and Environment. 274. 112756–112756. 3 indexed citations

Yu, J. Jessica, Hyein Lee, Buyun Kim, et al.. (2025). Astrocyte priming enhances microglial Aβ clearance and is compromised by APOE4. Nature Communications. 16(1). 7551–7551. 1 indexed citations

Shin, Jeonghyun, Hyunji Jo, Hyunjeong Kim, et al.. (2025). Computer-aided discovery of novel AMPK activators through virtual screening and SAR-driven synthesis. European Journal of Medicinal Chemistry. 287. 117318–117318. 1 indexed citations

Hwang, Soo‐Yeon, et al.. (2024). Synthesis and biological assessment of chalcone and pyrazoline derivatives as novel inhibitor for ELF3-MED23 interaction. eLife. 13.

Jo, Hyunji, Seri Park, Hye Ryeon Kim, et al.. (2022). Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort. Cancers. 14(19). 4839–4839. 6 indexed citations

Hwang, Soo‐Yeon, Seojeong Park, Hyunji Jo, et al.. (2022). Interrupting specific hydrogen bonds between ELF3 and MED23 as an alternative drug resistance-free strategy for HER2-overexpressing cancers. Journal of Advanced Research. 47. 173–187. 7 indexed citations

Yoon, Sang Eun, Junhun Cho, Young Hyeh Ko, et al.. (2022). Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma. Annals of Hematology. 101(7). 1535–1543. 4 indexed citations

Jo, Hyunji, Hong-Sik Kim, Jung Yong Hong, et al.. (2022). A Comparison of Folinic Acid, Fluorouracil and Irinotecan (FOLFIRI) plus Bevacizumab and FOLFIRI plus Aflibercept as Second-line Treatment for Metastatic Colorectal Cancer. Clinical Oncology. 34(8). e323–e328. 2 indexed citations

Park, Seojeong, Jae‐Ho Shin, Soo‐Yeon Hwang, et al.. (2022). Synthesis and evaluation of 7-(3-aminopropyloxy)-substituted flavone analogue as a topoisomerase IIα catalytic inhibitor and its sensitizing effect to enzalutamide in castration-resistant prostate cancer cells. European Journal of Medicinal Chemistry. 246. 114999–114999. 6 indexed citations

10.

Jo, Hyunji, Joo-Hyun Hong, Hong-Sik Kim, et al.. (2022). A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma. Frontiers in Oncology. 12. 874385–874385. 1 indexed citations

11.

Kim, Hong-Sik, Ryul Kim, Hye Ryeon Kim, et al.. (2022). HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer. Frontiers in Oncology. 12. 834104–834104. 21 indexed citations

12.

Kim, Hana, Hyo Jung Kim, Hong-Sik Kim, et al.. (2021). Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse Approach. Cancers. 13(22). 5835–5835. 9 indexed citations

13.

Jo, Hyunji, et al.. (2019). Analysis of phototoxin taste closely correlates nucleophilicity to type 1 phototoxicity. Proceedings of the National Academy of Sciences. 116(24). 12013–12018. 6 indexed citations

14.

Rahman, A. F. M. Motiur, Yang Lü, Hyunji Jo, et al.. (2018). Linear diarylheptanoids as potential anticancer therapeutics: synthesis, biological evaluation, and structure–activity relationship studies. Archives of Pharmacal Research. 41(12). 1131–1148. 18 indexed citations

15.

Magar, Til Bahadur Thapa, Tara Man Kadayat, Hyunji Jo, et al.. (2018). Synthesis and SAR study of new hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines as selective topoisomerase IIα-targeting anticancer agents. Bioorganic & Medicinal Chemistry. 26(8). 1909–1919. 19 indexed citations

16.

Shrestha, Aarajana, Hyunji Jo, Youngjoo Kwon, & Eung-Seok Lee. (2018). Design, synthesis, and structure-activity relationships of new benzofuro[3,2-b]pyridin-7-ols as DNA topoisomerase II inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(4). 566–571. 17 indexed citations

17.

Lee, Kiho, Hyunji Jo, Youngjoo Kwon, et al.. (2018). Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/IIα inhibitors. Bioorganic & Medicinal Chemistry. 26(18). 5181–5193. 12 indexed citations

18.

Jo, Hyunji, et al.. (2018). The synthesis and anticancer activities of chiral epoxy-substituted chromone analogs. Bioorganic Chemistry. 84. 347–354. 17 indexed citations

19.

Lee, Min Jung, Hyunji Jo, Hyung‐Wook Kim, et al.. (2017). Ionotropic Receptor 76b Is Required for Gustatory Aversion to Excessive Na+ in Drosophila. Molecules and Cells. 40(10). 787–795. 33 indexed citations

20.

Jo, Hyunji, A. Gringeri, Cindy Leissinger, et al.. (2011). PSY47 Evaluating the Cross-over Effect on Health-related Quality of Life in a Randomized Cross-over Study of Hemophilia-A Patients. Value in Health. 14(7). A418–A419. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact